切换导航
关闭
  • 菜单
  • Setting

Bcl Family Set I

 
Catalog No.
A9902
Bcl家族抑制剂
组合的产品项目
规格价格库存 数量
1 Set
¥ 818.00
Ship with 10-15 days

电话: 021-55669583

邮箱: sales@apexbio.cn

全球经销商

A

背景

ABT-737是Bcl-xL、Bcl-2和Bcl-w的BH3模拟抑制剂,EC50值分别为78.7 nM、30.3 nM和197.8 nM,对Mcl-1、Bcl-B和Bfl-1没有抑制作用。

WEHI-539对BCL-XL具有高亲和性(亚纳摩尔)和选择性,IC50值为1.1 nM,通过选择性拮抗BCL-XL的促存活活性,从而杀死细胞。

TW-37是一种新型非肽类抑制剂,作用于重组Bcl-2、Bcl-xL和Mcl-1,Ki值分别为0.29 μM、1.11 μM和0.26 μM。

ABT-263(Navitoclax)是一种有效的Bcl-xL、Bcl-2和Bcl-w抑制剂,Ki值分别为≤0.5 nM、≤1 nM和≤1 nM。

参考文献:
[1] Tahir S K, Yang X, Anderson M G, et al.  Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737[J]. Cancer research, 2007, 67(3): 1176-1183.
[2] Lessene G, Czabotar P E, Sleebs B E, et al.  Structure-guided design of a selective BCL-XL inhibitor. Nature chemical biology, 2013, 9(6): 390-397.
[3] Wang Z, Azmi A S, Ahmad A, et al.  TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and induces apoptosis in pancreatic cancer: involvement of Notch-1 signaling pathway. Cancer research, 2009, 69(7): 2757-2765.
[4] Mérino D1, Khaw SL, Glaser SP et al.  Bcl-2, Bcl-x(L), and Bcl-w are not equivalent targets of ABT-737 and navitoclax (ABT-263) in lymphoid and leukemic cells.Blood. 2012 Jun 14;119(24):5807-16.

Description

Formulation: DMSO solution
Long Term Storage: -20°C
Kit/Set Contains: Contains 25µl (10mM) each of the following inhibitors:
Cat.No.Product Name
A8193ABT-737
A3935WEHI-539
A4234TW-37
A3007ABT-263 (Navitoclax)